Skip to main content

Table 1 Clinic baseline characteristics of study subjects

From: Plasma exosome-derived microRNAs expression profiling and bioinformatics analysis under cross-talk between increased low-density lipoprotein cholesterol level and ATP-sensitive potassium channels variant rs1799858

  Genotypes of KATP rs1799858 P value
CC TT + TC
N 7 7
Male:female 4:3 4:3 1.000
Age (Y) 47.1 ± 9.0 45.9 ± 8.1 0.671
SBP (mmHg) 112.0 ± 12.7 116.6 ± 9.5 0.226
DBP (mmHg) 72.2 ± 10.2 74.8 ± 7.9 0.401
BMI (kg/m2) 24.5 ± 3.8 24.8 ± 2.6 0.793
TRIG (mmol/L) 1.13 ± 0.54 1.08 ± 0.55 0.812
TC (mmol/L) 3.89 ± 0.58 4.21 ± 0.96 0.237
LDL-C (mmol/L) 2.64 ± 0.52 2.86 ± 0.67 0.272
HDL-C(mmol/L) 1.40 ± 0.31 1.27 ± 0.21 0.178
Apo B (mg/dL) 55.1 ± 14.3 54.7 ± 14.8 0.935
Apo A1 (mg/dL) 143.7 ± 15.6 144.6 ± 23.0 0.890
WBC (× 109/L) 9.06 ± 3.84 8.36 ± 3.03 0.550
HGB (g/L) 136.0 ± 19.2 133.5 ± 13.6 0.655
PLT (× 109/L) 220.8 ± 52.6 241.8 ± 52.9 0.243
FBG (mmol/L) 5.27 ± 0.62 5.11 ± 0.60 0.456
P2hBS (mmol/L) 6.07 ± 2.82 6.50 ± 2.53 0.634
HbA1C (%) 5.1 ± 0.9 5.4 ± 0.8 0.357
Cr (μmol/L) 61.3 ± 14.8 64.1 ± 20.6 0.640
BUN (mmol/L) 5.02 ± 2.80 4.78 ± 1.92 0.765
UA (μmol/L) 364.5 ± 82.9 377.1 ± 97.2 0.676
ALT (U/L) 21.7 ± 18.4 25.4 ± 27.8 0.641
AST (U/L) 21.8 ± 9.7 23.7 ± 12.0 0.587
Alb (g/L) 37.6 ± 2.3 38.0 ± 4.7 0.730
Na+ (mmol/L) 139.9 ± 3.9 141.8 ± 2.7 0.099
K+ (mmol/L) 3.93 ± 0.37 3.88 ± 0.44 0.688
HsCRP (mg/L) 12.2 ± 13.2 13.8 ± 10.8 0.687
MAU (ACRa, mg/g) 306.9 ± 89.0 408.8 ± 361.4 0.242
HCY (μmol/L) 14.6 ± 6.9 14.1 ± 3.9 0.782
ACE (U/L) 31.2 ± 17.5 38.2 ± 20.9 0.278
Renin (pg/mL) 26.7 ± 32.4 26.9 ± 23.1 0.981
Ang I (ng/L) 2.82 ± 1.82 1.94 ± 1.29 0.105
Ang II (ng/L) 51.2 ± 37.0 62.4 ± 53.7 0.468
ALD (ng/L) 191.4 ± 101.6 170.0 ± 94.5 0.517
  1. aACR: urinary albumin-to-creatinine ratio